Research Report Screener Results

Chart, Historical Prices, News, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 20-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-May-13 GlobalData GlobalData Oncolytics Biotech Inc. (ONC) - Medical Equipment - Deals and Alliances Profile 23 $250 View Abstract
18-May-13 Reuters Investment Profile N/A Oncolytics Biotech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - ONCOLYTICS BIOTECH INCORPORATED (ONC-T) 10 $25 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine - Toronto Quantitative Stock Report for ONC 11 $126.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
6-May-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
24-Apr-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
11-Apr-13 Edison Investment Research Mr. Robin Davison, Dr. John Savin, Emma Ulker, Dr. Wang Chong, Ms. Lala Gregorek, Dr. Mick Cooper, Christian Glennie, Mr. Chris Kallos, Franc Gregori, Dr. Jason Zhang, Luke Poloniecki, Pooya Hemami PHARMACEUTICAL & HEALTHCARE - EDISON HEALTHCARE QUARTERLY: GERMAN (DRUG) REFORMATION 48 $10 View Abstract
8-Apr-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
4-Apr-13 GlobalData GlobalData Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review 41 $125 View Abstract

Independent Reports (Showing 1 to 10 of 10)

Release
Date Contributor Author Title Pages Price More Info
20-May-13 GlobalData GlobalData Oncolytics Biotech Inc. (ONC) - Medical Equipment - Deals and Alliances Profile 23 $250 View Abstract
18-May-13 Reuters Investment Profile N/A Oncolytics Biotech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $138 View Abstract
17-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - ONCOLYTICS BIOTECH INCORPORATED (ONC-T) 10 $25 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine - Toronto Quantitative Stock Report for ONC 11 $126.50 View Abstract
8-May-13 Edison Investment Research Mr. Robin Davison, Dr. Mick Cooper TRANSGENE - KEY TIME APPROACHES 12 $10 View Abstract
6-May-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
24-Apr-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
11-Apr-13 Edison Investment Research Mr. Robin Davison, Dr. John Savin, Emma Ulker, Dr. Wang Chong, Ms. Lala Gregorek, Dr. Mick Cooper, Christian Glennie, Mr. Chris Kallos, Franc Gregori, Dr. Jason Zhang, Luke Poloniecki, Pooya Hemami PHARMACEUTICAL & HEALTHCARE - EDISON HEALTHCARE QUARTERLY: GERMAN (DRUG) REFORMATION 48 $10 View Abstract
8-Apr-13 Alpha Street Research Hunter Orr Full Coverage Universe - Alpha Street 1-10 Ranking Overview 81 $48 View Abstract
4-Apr-13 GlobalData GlobalData Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review 41 $125 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.